JPRN-UMIN000047056已完成未知
J-RECOVER - J-RECOVER
ippon Medical School Musashikosugi Hospital0 个研究点目标入组 4,700 人开始时间: 2022年3月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 4,700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 1days-old 至 120years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •out of hospital cardiac arrest patient and died at the ED.
研究者
相似试验
招募中
1 期
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3938577 in Healthy Participants and Participants with Type 1 Diabetes Mellitus.Type 1 Diabetes MellitusCTIS2023-510365-10-00Eli Lilly & Co.70
招募中
不适用
Multi-Institutional Collaborative Study for Estimating the Persistence of Treatment Free Remission in Chronic Myeloid Leukemia after Stopping Tyrosine Kinase Inhibitor in JapaCML (chronic myeloid leukemia)JPRN-UMIN000037535THE JAPANESE SOCIETY OF HEMATOLOGY1,200
招募中
1 期
A Randomised Double-Blinded, Placebo-Controlled, Single and Multiple Ascending Dose, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3876602 in Healthy Participants.HealthyMedDRA version: 21.1Level: PTClassification code: 10053643Term: Neurodegenerative disorder Class: 100000004852CTIS2023-504838-21-00Eli Lilly & Co.69
已完成
不适用
Observation Study of Patients With Non-Small Cell Lung Cancer and Carcinomatous Meningitis Treated With whole-brain radiation or/and immune checkpoint inhibitors.on-small cell lung cancerJPRN-UMIN000040704orth East Japan Study Group (NEJSG)300
进行中（未招募）
不适用
未命名试验-MedDRA version: 16.1Level: LLTClassification code 10027475Term: Metastatic breast cancerSystem Organ Class: 100000004864EUCTR2012-004463-41-PTMedica Scientia Innovation Research (MedSIR ARO)60